Collectively, these findings establish succinylation as a key regulator in core AD pathology: it promotes Aβ pathology by modulating APP processing while accelerating neurofibrillary tangle formation by altering tau’s microtubule-binding capacity and aggregation properties, constituting a crucial molecular basis for AD progression (Figure 4). This evidence concerns the gene APP and Alzheimer disease.